-
Study aim
-
Evaluation of over-size stenting in patient with acute myocardial infarction undergoing primary percutaneous coronary intervention
-
Design
-
Single blinded parallel group randomized controlled trial
-
Settings and conduct
-
The trial will be held in a hospital setting. Patients will be randomized via central web based method into the interventional group (oversized stenting) and control group (conventional stenting) Patients will be blinded. Stenting outcome after the procedure and 6 months later will be evaluated.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: patients with acute ST elevation myocardial infarction who undergoing primary percutaneous coronary intervention.
Exclusion criteria: Primary percutaneous coronary intervention without stenting, on saphenus vein graft, on stent thrombosis and in rescue setting and unable to measure ST resolution.
-
Intervention groups
-
In interventional group, after diagnostic angiography, intracoronary nitroglycerin will be injected and infarcted vessel size in the proximal and distal section was measured by quantitative coronary analysis system . Then considering average of vessel diameter and operator decision the size of stent was chosen and 10% oversizing was done.In control group, after after diagnostic angiography, intracoronary nitroglycerin will be injected and infarcted vessel size in the proximal and distal section was measured by quantitative coronary analysis system . Then considering average of vessel diameter and operator decision the size of stent was chosen but it will not be oversized.
-
Main outcome variables
-
primary outcome: cardiac enzyme, ST-segment resolution, No-reflow phenomenon, Hospital stay days
Secondary outcome: Target vessel revascularization,Target lesion, revascularization, Reinfarction, All cause mortality, Cardiovascular mortality
Congestive heart failure, Cerebrovascular accident